ChiCTR1900027311
正在进行
/
/
/
2019-11-08
/
/
Mild Cognitive Impairment
Photo Neuro-Modulation Therapy to Adults
Photo Neuro-Modulation Therapy to Middle Aged and Older Adults with Mild Memory Problem
It is well-documented that mild cognitive impairment (MCI) is associated frontal lobe dysfunction and executive dysfunction. In addition, many studies reported high level of MCI symptoms among the elderly and the trend is increasing in Hong Kong. Based upon the link between MCI and frontal and executive function problems, it is conceivable that elderly who exhibits high levels of cognitive impairments would exhibit frontal and executive function problems. To our knowledge, there is still a lack of effective treatment or therapy for MCI, it is important to investigate effective intervention that can efficiently improve the cognitive ability of MCI patients. The objective of the present study is to compare individuals with MCI after the Photoneuromodulation Therapy (PNMT) and those who do not. A hundred and twenty middle aged and older adults were recruited from the subject database of the Neuropsychology Laboratory of The Chinese University of Hong Kong. Participants were divided randomly and equally into experimental group, as well as the control group. Several computerized executive function tests will be used before and after the treatment under the recording of near-infrared spectroscopy (NIRS) or Electroencephalography (EEG), which estimates level of frontal activation. The changes in hemodynamic response and brain waves will be recorded as well. It is hypothesized that compared to participants without PNMT, those with PNMT will have a better performance in the executive function tasks and exhibit a higher frontal activation as measured by the neuropsychological assessment. The cognitive and neurophysiological results would provide evidences on the possibility of PNMT in treating individuals with MCI, as well as with other mental disorders. In addition, PNMT may induce an addition, PNMT may induce an increase in frontal oxyhemoglobin, measured by NIRS, and increases in alpha and beta wave in EEG recordings, based on previous findings.
随机抽样
Ⅰ期
Randomized computer calculation
N/A
n/a
/
40
/
2020-02-03
2020-07-31
/
40 middle age and older adults with aged 40 or above who have subjective memory complaints;
请登录查看A history of head injury, or any neurological/psychiatric disorders, and dementia will be excluded. In addition, a score higher than 7 on the short form of the Chinese Geriatric Depression Scale (CGDS-SF; Lee, Chiu, Kwok, & Leung, 1993);
请登录查看香港中文大學威爾斯親王醫院心理學系
/
香港中文大學威爾斯親王醫院心理學系的其他临床试验
香港中文大學威爾斯親王醫院心理學系的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 60
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

